DBV Technologies | DBVT - Trade Creditors



DBV Technologies reported $40.79M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
Acadia Pharmaceuticals USD 20.1M 2M Jun/2025
Alnylam Pharmaceuticals USD 102.39M 4.99M Jun/2025
Amarin USD 45.66M 5.3M Mar/2025
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
DBV Technologies USD 40.79M 6.65M Jun/2025
Halozyme Therapeutics USD 18.69M 1.38M Jun/2025
Incyte USD 1.41B 1.21B Jun/2025
Insmed USD 78.35M 16.95M Jun/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
Neurocrine Biosciences 104.6M 5.4M Jun/2025
PTC Therapeutics USD 206.31M 191.16M Jun/2025
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
Ultragenyx Pharmaceutical USD 34.24M 13.21M Jun/2025
United Therapeutics 432M 426M Jun/2025